_id

691095acccc777a4e85d5b07

Ticker

ELDN

Name

Eledon Pharmaceuticals Inc

Exchange

NASDAQ

Address

19800 MacArthur Boulevard, Irvine, CA, United States, 92612

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://eledon.com

Description

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for the prevention of allograft rejection in kidney transplantation and xenotransplantation. The company has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.

Last Close

1.7

Volume

730401

Current Price

1.695

Change

-0.29411764705881727

Last Updated

2025-11-29T12:39:45.870Z

Image

data:image/webp;base64,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

Ipo Date

2014-09-17T00:00:00.000Z

Market Cap

122305848

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.4508000000000001

Sentiment Sources

5

Rating

4.8333

Target Price

8

Strong Buy

5

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

19070000

Operating Income

-19070000

Interest Expense

-

Pretax Income

-17459000

Net Income

-17459000

Eps

-0.22628161922403822

Dividends Per Share

-

Shares Outstanding

75034260

Income Tax Expense

-

EBITDA

-17459000

Operating Margin

-

Total Other Income Expense Net

1611000

Cash

3669000

Short Term Investments

89732000

Receivables

753000

Inventories

-

Total Current Assets

96301000

Property Plant Equipment

694000

Total Assets

129857000

Payables

4627000

Short Term Debt

346000

Long Term Debt

-

Total Liabilities

94497000

Equity

35360000

Depreciation

-

Change In Working Capital

2819000

Cash From Operations

-14477000

Capital Expenditures

0

Cash From Investing

12405000

Cash From Financing

0

Net Change In Cash

-2072000

PE

-

PB

3.6985162686651587

ROE

-49.375

ROA

-13.444789268195015

FCF

-14477000

Fcf Percent

-

Piotroski FScore

1

Health Score

24

Deep Value Investing Score

1.5

Defensive Investing Score

5.5

Dividend Investing Score

1.5

Economic Moat Investing Score

2.8

Garp Investing Score

0.5

Growth Investing Score

0.5

Momentum Investing Score

2.5

Net Net Investing Score

2.5

Quality Investing Score

1

Value Investing Score

2

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

19070000

Quarters > 0 > income Statement > operating Income

-19070000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-17459000

Quarters > 0 > income Statement > net Income

-17459000

Quarters > 0 > income Statement > eps

-0.22628161922403822

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

77156068

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-17459000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

1611000

Quarters > 0 > balance Sheet > cash

3669000

Quarters > 0 > balance Sheet > short Term Investments

89732000

Quarters > 0 > balance Sheet > receivables

753000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

96301000

Quarters > 0 > balance Sheet > property Plant Equipment

694000

Quarters > 0 > balance Sheet > total Assets

129857000

Quarters > 0 > balance Sheet > payables

4627000

Quarters > 0 > balance Sheet > short Term Debt

346000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

94497000

Quarters > 0 > balance Sheet > equity

35360000

Quarters > 0 > cash Flow > net Income

-17459000

Quarters > 0 > cash Flow > depreciation

-

Quarters > 0 > cash Flow > change In Working Capital

2819000

Quarters > 0 > cash Flow > cash From Operations

-14477000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

12405000

Quarters > 0 > cash Flow > cash From Financing

0

Quarters > 0 > cash Flow > net Change In Cash

-2072000

Quarters > 0 > ratios > PE

-0.22628161922403822

Quarters > 0 > ratios > PB

3.6985162686651587

Quarters > 0 > ratios > ROE

-49.375

Quarters > 0 > ratios > ROA

-13.444789268195015

Quarters > 0 > ratios > FCF

-14477000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

24

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

24733000

Quarters > 1 > income Statement > operating Income

-24733000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-11216000

Quarters > 1 > income Statement > net Income

-11216000

Quarters > 1 > income Statement > eps

-0.14536769810509265

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

77156068

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-24733000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

13517000

Quarters > 1 > balance Sheet > cash

5741000

Quarters > 1 > balance Sheet > short Term Investments

101829000

Quarters > 1 > balance Sheet > receivables

705000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

111404000

Quarters > 1 > balance Sheet > property Plant Equipment

773000

Quarters > 1 > balance Sheet > total Assets

144909000

Quarters > 1 > balance Sheet > payables

5831000

Quarters > 1 > balance Sheet > short Term Debt

336000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

38881000

Quarters > 1 > balance Sheet > equity

106028000

Quarters > 1 > cash Flow > net Income

-11216000

Quarters > 1 > cash Flow > depreciation

-

Quarters > 1 > cash Flow > change In Working Capital

3457000

Quarters > 1 > cash Flow > cash From Operations

-17713000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

14958000

Quarters > 1 > cash Flow > cash From Financing

0

Quarters > 1 > cash Flow > net Change In Cash

-2755000

Quarters > 1 > ratios > PE

-0.14536769810509265

Quarters > 1 > ratios > PB

1.2334433853321765

Quarters > 1 > ratios > ROE

-10.578337797562908

Quarters > 1 > ratios > ROA

-7.740029949830583

Quarters > 1 > ratios > FCF

-17713000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

42

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

17964000

Quarters > 2 > income Statement > operating Income

-17964000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-6495000

Quarters > 2 > income Statement > net Income

-6495000

Quarters > 2 > income Statement > eps

-0.08421201340966429

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

77126763

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-6494999

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

11469000

Quarters > 2 > balance Sheet > cash

8496000

Quarters > 2 > balance Sheet > short Term Investments

116385000

Quarters > 2 > balance Sheet > receivables

761000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

127718000

Quarters > 2 > balance Sheet > property Plant Equipment

850000

Quarters > 2 > balance Sheet > total Assets

161308000

Quarters > 2 > balance Sheet > payables

2901000

Quarters > 2 > balance Sheet > short Term Debt

325000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

46728000

Quarters > 2 > balance Sheet > equity

114580000

Quarters > 2 > cash Flow > net Income

-6495000

Quarters > 2 > cash Flow > depreciation

17964000

Quarters > 2 > cash Flow > change In Working Capital

-1753000

Quarters > 2 > cash Flow > cash From Operations

-16060000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

3892000

Quarters > 2 > cash Flow > cash From Financing

115000

Quarters > 2 > cash Flow > net Change In Cash

-12053000

Quarters > 2 > ratios > PE

-0.08421201340966429

Quarters > 2 > ratios > PB

1.1409483617123406

Quarters > 2 > ratios > ROE

-5.668528539012044

Quarters > 2 > ratios > ROA

-4.026458700126466

Quarters > 2 > ratios > FCF

-16060000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

42

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

384000

Quarters > 3 > income Statement > cost Of Revenue

88000

Quarters > 3 > income Statement > gross Profit

-88000

Quarters > 3 > income Statement > operating Expenses

24608000

Quarters > 3 > income Statement > operating Income

-24696000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-44186000

Quarters > 3 > income Statement > net Income

-44617000

Quarters > 3 > income Statement > eps

-0.7462375150058267

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

59789275

Quarters > 3 > income Statement > income Tax Expense

431000

Quarters > 3 > income Statement > EBITDA

-44098000

Quarters > 3 > income Statement > operating Margin

-6431.25

Quarters > 3 > income Statement > total Other Income Expense Net

-19490000

Quarters > 3 > balance Sheet > cash

20549000

Quarters > 3 > balance Sheet > short Term Investments

119629000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

143730000

Quarters > 3 > balance Sheet > property Plant Equipment

926000

Quarters > 3 > balance Sheet > total Assets

177405000

Quarters > 3 > balance Sheet > payables

5833000

Quarters > 3 > balance Sheet > short Term Debt

314000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

59265000

Quarters > 3 > balance Sheet > equity

118140000

Quarters > 3 > cash Flow > net Income

-44617000

Quarters > 3 > cash Flow > depreciation

88000

Quarters > 3 > cash Flow > change In Working Capital

-1517000

Quarters > 3 > cash Flow > cash From Operations

-18987000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-47382000

Quarters > 3 > cash Flow > cash From Financing

80167000

Quarters > 3 > cash Flow > net Change In Cash

13798000

Quarters > 3 > ratios > PE

-0.7462375150058267

Quarters > 3 > ratios > PB

0.857819714956831

Quarters > 3 > ratios > ROE

-37.76620958185204

Quarters > 3 > ratios > ROA

-25.149798483695502

Quarters > 3 > ratios > FCF

-18987000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-49.4453125

Quarters > 3 > health Score

30

Valuation > metrics > PE

-0.22628161922403822

Valuation > metrics > PB

3.6985162686651587

Valuation > final Score

43.014837313348416

Valuation > verdict

23.3% Overvalued

Profitability > metrics > ROE

-49.375

Profitability > metrics > ROA

-18.12961443806399

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

2.6724264705882352

Risk > final Score

38

Risk > verdict

High

Liquidity > metrics > Current Ratio

19.364769756686105

Liquidity > metrics > Quick Ratio

19.364769756686105

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

53

Prev Risks > 1

-71855940

Prev Risks > 2

-1075

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-13T00:37:00.304Z